Bio-Rad’s Coronavirus Ag Rapid Test, an antigen test used to detect the nucleocapsid protein antigen in SARS-CoV-2, offers new flexibility in detecting SARS-CoV-2 and now includes a quality control (QC) swab kit.
The Coronavirus Ag Rapid Test and QC swab kits are included in the official list of antigen tests recommended by several European governments for the detection of the nucleocapsid protein, which is found in SARS-CoV-2. The rapid in vitro immunochromatographic test provides a quick and easy way to detect the SARS-CoV-2 antigen in the early stages of infection. Offering convenience and flexibility, the test can be used in a laboratory or in a point-of-care setting, and met CE-mark requirements for European markets earlier this year.
Clinical evaluation of the Coronavirus Ag Rapid Test was performed at seven test sites with 237 fresh nasal swab specimens and 865 fresh nasopharyngeal swab specimens collected and tested in a randomised blinded study. The test demonstrated high performance for both nasal and nasopharyngeal swab specimens, with 100% and 99.60% specificity, and 97.25% and 98.32% sensitivity, respectively, at the test sites.
Please visit www.bio-rad.com/en-fr/product/sars-cov-2-ag-rdt-format?ID=QN7X12TU86LJ to learn more about the Coronavirus Ag Rapid Test.
